These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6922944)

  • 1. Penicillin gets some help against resistant pathogens.
    Henehan J
    JAMA; 1982 Nov; 248(19):2427. PubMed ID: 6922944
    [No Abstract]   [Full Text] [Related]  

  • 2. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
    Kawamura S; Sugita R; Fujimaki Y; Deguchi K
    Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates.
    Van Landuyt HW; Pyckavet M; Lambert AM
    J Antimicrob Chemother; 1981 Jan; 7(1):65-70. PubMed ID: 6907270
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) in the fields of obstetrics and gynecology].
    Kishida H; Kisaka Y; Matsubayashi S; Hiraoka H; Naitoh H; Tanaka S; Urabe T; Fujiwara A
    Jpn J Antibiot; 1983 Mar; 36(3):487-99. PubMed ID: 6553605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentin: an in vitro study of bacterial sensitivities to a synergistic combination.
    Neville MA
    N Z Med J; 1982 Aug; 95(714):579-81. PubMed ID: 6982440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaceutical preparation of BRL 25000].
    Jpn J Antibiot; 1985 Feb; 38(2):538-41. PubMed ID: 3847526
    [No Abstract]   [Full Text] [Related]  

  • 8. Media factors affecting Augmentin disc sensitivity testing results.
    Brown EM; Ribeiro CD
    J Antimicrob Chemother; 1982 Jul; 10(1):75-7. PubMed ID: 6921200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB; Lang SD; Downey DJ; Anderson MP
    N Z Med J; 1982 Aug; 95(713):542-5. PubMed ID: 6752781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sunakawa K; Ishizuka Y
    Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
    Focht J; Klietmann W; Heilmann HD
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ; Ibrahim ME; Gill KP
    Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential sensitivities to amoxycillin/clavulanate and amoxycillin in general practice urinary infections.
    Brumfitt W; Hamilton-Miller JM
    Lancet; 1983 Sep; 2(8349):566. PubMed ID: 6136712
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy of augmentin as a beta-lactam antibiotic in surgical and medical practice.
    Kirei BR; Mhalu FS; Pallangyo PK; Seif SA
    East Afr Med J; 1987 Jul; 64(7):499-503. PubMed ID: 3691365
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
    Glupczynski Y; McGillavry G; Yourassowsky E
    Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics.
    Perryman F; Johnson S; Qadri SM
    Chemotherapy; 1983; 29(2):111-5. PubMed ID: 6839863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of Augmentin and co-trimoxazole in the treatment of adult infections in general practice.
    Davies JG; Rose AJ; Walker GD
    Br J Clin Pract; 1982 Dec; 36(11-12):387-93, 403. PubMed ID: 6984654
    [No Abstract]   [Full Text] [Related]  

  • 20. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.